Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Mermel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|January 14, 2022
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challengeWouter Bulten, Kimmo Kartasalo, Po-Hsuan Cameron Chen, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature|June 18, 2013
Mutational heterogeneity in cancer and the search for new cancer-associated genesMichael S Lawrence, Petar Stojanov, Paz Polak, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|January 14, 2022
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challengeWouter Bulten, Kimmo Kartasalo, Po-Hsuan Cameron Chen, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature|June 18, 2013
Mutational heterogeneity in cancer and the search for new cancer-associated genesMichael S Lawrence, Petar Stojanov, Paz Polak, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
Pageof 5